Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
Shiraishi
M
M
Department of Surgery, UCLA Medical Center.
Shaked
A
A
Yasunaga
C
C
Hasuike
Y
Y
Imagawa
D K
DK
Busuttil
R W
RW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D003141:Communicable Diseases / Q000150:complications*; D004797:Enzyme-Linked Immunosorbent Assay; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000276:immunology; D016031:Liver Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011919:Rats, Inbred Strains; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha